ArticleAdvances in radiation oncology2026
Sexual Toxicity After Chemoradiation for Anal Cancer Among Men Who Have Sex With Men: A Mixed-Methods Analysis.
Article in Advances in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
Abstract
Purpose: Chemoradiation (CRT) is the standard of treatment for localized anal squamous cell carcinoma (SCCA). Although cure rates are high, acute and late toxicities are common. There are increasing published data regarding vaginal stenosis and erectile dysfunction; however, the nature and impact of holistic sexual dysfunction after pelvic radiation, particularly among men who have sex with men (MSM), remains poorly characterized. This study aimed to: (1) explore patient-reported sexual health outcomes among MSM as measured by existing patient-reported outcome tools, and (2) assess the applicability of these existing tools for this population. Methods and Materials: MSM who are at least 6 months out from completion of CRT for SCCA were recruited via fliers and online platforms. Participants completed a sexual patient-reported outcome questionnaire that included previously validated instruments assessing symptom burden, sexual function and satisfaction, erectile function, and pain with receptive anal intercourse. This was followed by a semistructured interview. Descriptive statistics were used to report demographics and survey data. McNemar's test compared sexual activities pre- and post-CRT. Interview data were thematically analyzed using inductive coding. Results: Of the 23 participants who completed the questionnaire, 19 completed an interview. The median (IQR) time since completing CRT was 3.1 (1.2-4.8) years. Approximately half (N = 11) had moderate to severe erectile dysfunction (median International Index of Erectile Function [IIEF-5] = 12; IQR, 6-20). Since completing treatment, 9 (39.1%) had attempted receptive anal penetration. Of those who had attempted receptive anal penetration, 66.7% experienced pain, and an equal percentage reported moderate-severe distress and interpersonal/relationship difficulty as a result. In general, patients reported participating in fewer sexual activities after CRT. Emergent themes from interviews included the need for patient education, the interplay between other radiation side effects and sexual side effects, and positive reactions to the survey measures. Conclusions: Sexual dysfunction is common among MSM following CRT for SCCA. Erectile dysfunction and/or pain with receptive anal intercourse often lead to distress and interpersonal relationship challenges. Improved patient education and targeted interventions are needed to support sexual function and quality of life in this population.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.